George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 139,644 shares at $42.14 ($5.9M) on 2021-04-14, disclosed to the SEC on 2021-04-16.
Open-market sale of $5.9M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.12 | 13,924 | $586K | 10.0% |
| 2 | $42.12 | 13,924 | $586K | 10.0% |
| 3 | $42.14 | 55,898 | $2.4M | 40.0% |
| 4 | $42.14 | 55,898 | $2.4M | 40.0% |
| Total | $42.14 avg | 139,644 | $5.9M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |